Stock Taper
EARNINGS CALL ARCHIVE 4 CALLS ON FILE
NUVB — Nuvation Bio Inc.
NYSE
FULL STOCK PAGE →

Q2 2026 Earnings Call Summary

AUG 6, 2026
REVENUE
$31.7M -61.9%
NET MARGIN
-198.3% -204.8 PTS
EPS
-$0.18 -1261.3%
FREE CASH FLOW
-$5.0M -200.0%

No summary has been written for this call yet.